Zentalis director granted 114,200 RSUs
Campbell Shannon reported acquisition or exercise transactions in this Form 4 filing.
Rhea-AI Filing Summary
Campbell Shannon reported acquisition or exercise transactions in this Form 4 filing.
Zentalis Pharmaceuticals director Shannon Campbell received an equity grant in the form of restricted stock units. The award covers 114,200 shares of common stock at no purchase price, granted under the company’s Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, contingent on continued board service, resulting in 114,200 shares reported as directly owned after this grant.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 114,200 shares
Grant/Award
1 txn
Insider
Campbell Shannon
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 114,200 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 114,200 shares (Direct)
Footnotes (1)
- F1. The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program. One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date, subject to the reporting person's continued service with the Issuer on each vesting date.
Key Figures
RSU grant size: 114,200 shares
Purchase price per share: $0.00 per share
Post-transaction holdings: 114,200 shares
+1 more
4 metrics
RSU grant size
114,200 shares
Restricted stock units granted to director on Form 4
Purchase price per share
$0.00 per share
RSUs granted at no purchase price
Post-transaction holdings
114,200 shares
Common stock reported as directly owned after grant
Vesting schedule
1/3 each year over 3 years
On first, second and third anniversaries of grant date
Key Terms
restricted stock units, RSUs, Non-Employee Director Compensation Program, vest
4 terms
restricted stock units financial
"The restricted stock units ("RSUs") were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program."
Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.
RSUs financial
"One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date"
RSUs, or restricted stock units, are a form of company shares given to employees as part of their compensation. They are typically awarded with certain restrictions, such as a waiting period before they can be fully owned or sold, similar to earning a gift that becomes fully yours over time. For investors, RSUs can impact a company's stock offerings and reflect how much the company relies on stock-based incentives to attract and retain talent.
Non-Employee Director Compensation Program financial
"The RSUs were granted by the Issuer pursuant to the Issuer's Non-Employee Director Compensation Program."
vest financial
"One third of the RSUs will vest on each of the first, second and third anniversaries of the grant date"
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Zentalis Pharmaceuticals (ZNTL) report for Shannon Campbell?
Zentalis Pharmaceuticals reported that director Shannon Campbell received a grant of 114,200 restricted stock units, representing an equity award rather than an open-market trade. The RSUs were issued at no purchase price under the company’s Non-Employee Director Compensation Program.
How do Shannon Campbell’s RSUs at Zentalis (ZNTL) vest over time?
The RSUs granted to Shannon Campbell vest in three equal installments. One third of the 114,200 restricted stock units will vest on each of the first, second and third anniversaries of the grant date, conditioned on continued service with Zentalis.
Was Shannon Campbell’s Zentalis (ZNTL) equity grant an open-market purchase?
No, the filing shows the transaction as a grant or award coded “A,” not an open-market purchase. Campbell received 114,200 restricted stock units at no purchase price under the Non-Employee Director Compensation Program as part of board compensation.
What is the purpose of Zentalis’s Non-Employee Director Compensation Program mentioned in the filing?
The Non-Employee Director Compensation Program provides equity awards such as restricted stock units to directors who are not company employees. In this case, it granted Shannon Campbell 114,200 RSUs, aligning director compensation with the performance of Zentalis Pharmaceuticals’ common stock.
AI-generated analysis. How Rhea-AI works. Not financial advice.
